Literature DB >> 9408305

Prognosis of untreated liver metastasis from rectal cancer.

D Görög1, A Tóth, J Weltner.   

Abstract

UNLABELLED: Majority of studies based of treatment of liver metastases from colorectal cancer compare their results to historical controls that include patients having untreated secondary liver tumours. The aim of this study was to show the natural history of patients with liver metastasis from rectal cancer. Data of 303 patients underwent laparotomy between 1984 and 1992 were reviewed. 47 of 57 patients who had liver metastasis at the time of surgery fulfilled the criteria of the study. The mean survival time was 8.5 (1-27) months for all patients, 11 months for patients with solitary hepatic tumour (n = 13) and 7.5 months for those with multiple tumours (n = 34). Patients who had liver and other distant metastases simultaneously (n = 9) survived a shorter time than those with hepatic secondaries only (4 and 9 months respectively). The mean survival time for patients in whom the primary tumour was resected (n = 17) was 11 months contrary to 7 months for those who underwent colostomy or exploratory laparotomy, but comparison of survival curves didn't revealed significant difference between the two groups.
CONCLUSIONS: The incidence of liver metastases from rectal cancer at the time of laparotomy was 19%. The prognosis was very poor in case of synchronous secondary tumours. Palliative resection of the primary tumour is recommended for selected patients only to control local symptoms.

Entities:  

Mesh:

Year:  1997        PMID: 9408305

Source DB:  PubMed          Journal:  Acta Chir Hung        ISSN: 0231-4614


  9 in total

1.  Hepatic arterial infusion after curative resection of colorectal cancer metastases: a meta-analysis of prospective clinical trials.

Authors:  Thomas E Clancy; Elijah Dixon; Roy Perlis; Francis R Sutherland; Michael J Zinner
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

2.  Epidemiology of primary and secondary liver cancers.

Authors:  Ashwin Ananthakrishnan; Veena Gogineni; Kia Saeian
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

3.  A cost-utility analysis of treatments for malignant liver tumours: a pilot project.

Authors:  Andrew McKay; Trish Kutnikoff; Mark Taylor
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

4.  Role of Liver Biopsy in Assessment of Radiologically Identified Liver Masses.

Authors:  Ali Khalifa; Roula Sasso; Don C Rockey
Journal:  Dig Dis Sci       Date:  2021-02-19       Impact factor: 3.199

Review 5.  Stereotactic radiotherapy for liver oligometastases.

Authors:  Claudia Menichelli; Franco Casamassima; Cynthia Aristei; Gianluca Ingrosso; Simona Borghesi; Fabio Arcidiacono; Valentina Lancellotta; Ciro Franzese; Stefano Arcangeli
Journal:  Rep Pract Oncol Radiother       Date:  2022-03-22

6.  Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy.

Authors:  Gennaro Nuzzo; Felice Giuliante; Francesco Ardito; Maria Vellone; Carmelo Pozzo; Alessandra Cassano; Ivo Giovannini; Carlo Barone
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.267

7.  Nomogram for predicting occurrence and prognosis of liver metastasis in colorectal cancer: a population-based study.

Authors:  Mingshuang Tang; Hongmei Wang; Yitong Cao; Ziqian Zeng; Xuefeng Shan; Lihua Wang
Journal:  Int J Colorectal Dis       Date:  2020-09-23       Impact factor: 2.796

Review 8.  Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies.

Authors:  P C Simmonds; J N Primrose; J L Colquitt; O J Garden; G J Poston; M Rees
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

9.  Preoperative CT versus diffusion weighted magnetic resonance imaging of the liver in patients with rectal cancer; a prospective randomized trial.

Authors:  Michael P Achiam; Vibeke B Løgager; Bjørn Skjoldbye; Jakob M Møller; Torben Lorenzen; Vera L Rasmussen; Henrik S Thomsen; Talie H Mollerup; Cecilie Okholm; Jacob Rosenberg
Journal:  PeerJ       Date:  2016-01-14       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.